Filter Results :

Your search for Biopharmaceutical returned 86 reports

Sort by


Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2015

20 May 2015  |  Published by:  Global Markets Direct
Summary‘Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2015’, provides an overview of the Asklepios BioPharmaceutical, Inc.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Asklepios Bio...

$ 1,500.00

Read More

Single-Use Technologies for Biopharmaceuticals: Global Markets

20 May 2015  |  Published by:  BCC Research
The global revenue for single use technology reached $1.4 billion and $1.7 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.7% to nearly $3.0 billion for the period 2014-2019. This report provides:-An overview of biopharm...

$ 6,650.00

Read More

Antibody Production Market by Product (Equipment, Consumables), Type (Monoclonal, Polyclonal), Technology (Hybridoma) & by End-User (Biopharmaceutical Companies, Diagnostic Labs, Research Institutes) - Analysis & Global Forecast to 2019

01 May 2015  |  Published by:  MarketsandMarkets
Report Description Over the years, the antibody production market has witnessed various technological advancements in order to produce antibodies that meet the needs of biotechnology and biopharmaceutical companies, diagnostic laboratories, and research institutes. These advancements have l...

$ 4,650.00

Read More

Transposagen Biopharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

24 Apr 2015  |  Published by:  GlobalData
SummaryTransposagen Biopharmaceuticals, Inc. (Transposagen) is a biotechnology company. The company provides animal models, cell lines, stem cells and research tools and technologies for drug discovery and development research. Its gene modification tools include Footprint-Free Gene Editing, XTN TAL...

$ 250.00

Read More

PlasmaTech Biopharmaceuticals, Inc. (PTBI) - Medical Equipment - Deals and Alliances Profile

24 Apr 2015  |  Published by:  GlobalData
SummaryPlasmaTech Biopharmaceuticals, Inc., (PlasmaTech) is a biopharmaceutical company. It develops novel medicines for the treatment of cancer and supportive care of cancer patients. The company’s product MuGard for the management of patients with mucositis is approved in the US, EU, China and Sou...

$ 250.00

Read More

Navidea Biopharmaceuticals, Inc. (NAVB) - Medical Equipment - Deals and Alliances Profile

20 Apr 2015  |  Published by:  GlobalData
SummaryNavidea Biopharmaceuticals, Inc. (Navidea) is a biopharmaceutical company focused on the development and commercialization of radiopharmaceutical agents and precision diagnostics. The company's pipeline products include Lymphoseek, a radiopharmaceutical agent for lymph node mapping for the di...

$ 250.00

Read More

Provectus Biopharmaceuticals, Inc. (PVCT) - Medical Equipment - Deals and Alliances Profile

10 Apr 2015  |  Published by:  GlobalData
SummaryProvectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 for atopic dermatitis, PV-10 for metastatic liver cancer, PV-10 for recurrent breast cancer and P...

$ 250.00

Read More

Sino Biopharmaceutical Limited (1177) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummarySino Biopharmaceutical Limited (Sino) is a pharmaceutical company. The company operates through Chinese Medicines and Chemical Medicines segment, Investment Segment, and Other Segments. Its Chinese medicines and chemical medicines segment manufactures, sells and distributes modernized Chinese...

$ 300.00

Read More

Kythera Biopharmaceuticals, Inc. (KYTH) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummaryKythera Biopharmaceuticals, Inc. (Kythera) is a biopharmaceutical company. The company discovers, develops and commercializes prescription products for the aesthetic medicine market. Its pipeline product include ATX-101. Kythera’s ATX-101 is an injectable drug, which is currently in late stag...

$ 300.00

Read More

Provectus Biopharmaceuticals, Inc. (PVCT) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummaryProvectus Biopharmaceuticals, Inc. (Provectus) is a pharmaceutical company. The company develops and offers oncology therapies. Its products include PV-10 for melanoma, PH-10 for psoriasis, PH-10 for atopic dermatitis, PV-10 for metastatic liver cancer, PV-10 for recurrent breast cancer and P...

$ 300.00

Read More

XTL Biopharmaceuticals Ltd. (XTLB) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummaryXTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company. It carries out the acquisition and development of proprietary products. It focuses on the development of late stage pharmaceutical products in the areas of unmet clinical needs. The company has three product candidates such as ...

$ 300.00

Read More

Accentia Biopharmaceuticals, Inc. (ABPI) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummaryAccentia Biopharmaceuticals, Inc. (Accentia) is a biotechnology company. It identifies, develops and commercializes patent-protected disruptive healthcare technologies for the treatment of chronic and life threatening diseases including the respiratory, autoimmune and cancer indications. The ...

$ 300.00

Read More

RegeneRx Biopharmaceuticals, Inc. (RGRX) - Financial and Strategic SWOT Analysis Review

06 Apr 2015  |  Published by:  GlobalData
SummaryRegeneRx Biopharmaceuticals, Inc. (RegeneRx Biopharmaceuticals) is a biopharmaceutical company. The company designs, researches and develops peptides targeted at diseases with unmet medical needs. Its pharmaceuticals protect and repair tissue and organ damage caused by disease, trauma or othe...

$ 300.00

Read More

SK Biopharmaceuticals Co., Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30 Mar 2015  |  Published by:  GlobalData
SummarySK Biopharmaceuticals Co., Ltd. (SK Biopharmaceuticals) is a pharmaceutical company. It develops innovative drugs for the treatment of central nervous system (CNS) disorders such as epilepsy, anxiety, depression, schizophrenia, Parkinson's disease, irritable bowel syndrome; and metabolic diso...

$ 250.00

Read More

XTL Biopharmaceuticals Ltd. (084990) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

30 Mar 2015  |  Published by:  GlobalData
SummaryXTL Biopharmaceuticals Ltd. (XTL) is a biopharmaceutical company. It carries out the acquisition and development of proprietary products. It focuses on the development of late stage pharmaceutical products in the areas of unmet clinical needs. The company has three product candidates such as ...

$ 250.00

Read More
Total 86 records.